The Company

Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses the most advanced technology to supply physicians with a novel diagnostic tool and thereby provide patients with personal allergy profiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection.

Abionic SA is a privately held high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab. The company also benefits from coaching of Genilem, the A3 Angels mentoring program and the CTI coaching.

Abionic was founded in 2010 by former scientists of the biomedical optics laboratory (LOB) at EPFL. The headquarters are located in Lausanne, Switzerland.

They support us: